Bifendate/Inosine/Ascorbic Acid

联苯双酯/肌苷/维生素C

Report date: 2025/07/18 17:33:11

Base Information

Drug NameBifendate/Inosine/Ascorbic Acid
Drug Alias Name复方联苯双酯
ClassificationSmall molecules
Mechanisms of ActionApoptosis stimulantsCell cycle inhibitorsBeta-nerve growth factor stimulants +[4] 
TargetsBeta-nerve growth factor
Therapy Area/IndicationsHepatitis
Global Approved IndicationsHepatitis
Approved Indications in ChinaHepatitis
Original Approved Country/TerritoryMainland China
Original Approved Date1987/01/01
Country/TerritoryMainland China
CombinationsYes BifendateInosineAscorbic Acid
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHeilongjiang Fuhe Huaxing Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHeilongjiang Fuhe Huaxing Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A